Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Disc Medicine, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +10 vs. Q4 2022
- Shares held
- 14.6M
- +3.17M (+27.7%) vs. Q4 2022
- Total value
- $309.6M
- +$93.8M (+43.5%) vs. Q4 2022
- New holders
- 13
- 14 more added
- Sold out
- 3
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCI Wealth Advisors, Inc. | 20 | $424 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 26 | $551 | 0.00% | +26 | New |
| Ulland Investment Advisors, LLC | 34 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 100 | $2.00K | 0.00% | +100 | New |
| Steward Partners Investment Advisory, LLC | 300 | $6.36K | 0.00% | +300 | New |
| US Bancorp | 1,176 | $24.9K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,682 | $56.8K | 0.00% | +2,680+134,000.0% | Added |
| UBS Group AG | 5,243 | $111.1K | 0.00% | −1,872−26.3% | Reduced |
| Barclays PLC | 5,619 | $119.1K | 0.00% | +5,419+2,709.5% | Added |
| Morgan Stanley | 9,815 | $208.0K | 0.00% | +8,994+1,095.5% | Added |
| Velan Capital Investment Management LP | 12,269 | $260.0K | 0.23% | +12,269 | New |
| Stifel Financial Corp | 13,722 | $290.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 14,487 | $307.0K | 0.00% | +4,298+42.2% | Added |
| Renaissance Technologies LLC | 15,270 | $324.0K | 0.00% | +2,300+17.7% | Added |
| Jane Street Group, LLC | 19,252 | $407.9K | 0.00% | +19,252 | New |
| Goldman Sachs Group Inc | 21,674 | $459.3K | 0.00% | +21,674 | New |
| Millennium Management LLC | 22,107 | $468.0K | 0.00% | +7,346+49.8% | Added |
| BlackRock Inc. | 23,467 | $497.3K | 0.00% | +3,385+16.9% | Added |
| Two Sigma Investments, LP | 24,150 | $511.7K | 0.00% | +24,150 | New |
| Harvard Management Co Inc | 25,000 | $529.8K | 0.06% | 00.0% | Unchanged |
| Citigroup Inc | 25,080 | $531.4K | 0.00% | +19,993+393.0% | Added |
| Susquehanna International Group, LLP | 37,213 | $788.5K | 0.00% | +37,213 | New |
| Janus Henderson Group PLC | 43,698 | $926.0K | 0.00% | −456,632−91.3% | Reduced |
| UBS Oconnor LLC | 45,750 | $969.4K | 0.02% | +45,750 | New |
| Geode Capital Management, LLC | 47,038 | $996.7K | 0.00% | +19,878+73.2% | Added |
| Assenagon Asset Management S.A. | 61,805 | $1.31M | 0.01% | −6,621−9.7% | Reduced |
| ExodusPoint Capital Management, LP | 70,966 | $1.50M | 0.02% | +40,734+134.7% | Added |
| Nantahala Capital Management, LLC | 89,538 | $1.90M | 0.18% | −73,224−45.0% | Reduced |
| Ghost Tree Capital, LLC | 100,000 | $2.12M | 0.80% | +100,000 | New |
| Trustees of Columbia University in the City of New York | 110,488 | $2.34M | 4.19% | 00.0% | Unchanged |
| Boxer Capital, LLC | 130,000 | $2.75M | 0.14% | 00.0% | Unchanged |
| FMR LLC | 151,699 | $3.21M | 0.00% | −41,539−21.5% | Reduced |
| Citadel Advisors LLC | 171,238 | $3.63M | 0.00% | +115,560+207.6% | Added |
| BML Capital Management, LLC | 208,161 | $4.41M | 3.81% | −291,839−58.4% | Reduced |
| Sphera Funds Management Ltd. | 220,013 | $4.66M | 1.01% | +220,013 | New |
| Foresite Capital Management V, LLC | 243,513 | $5.16M | 3.81% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 313,468 | $6.64M | 0.16% | −26,029−7.7% | Reduced |
| Vanguard Group Inc | 322,869 | $6.84M | 0.00% | +267,006+478.0% | Added |
| Logos Global Management LP | 525,000 | $11.1M | 1.59% | +525,000 | New |
| 5AM Venture Management, LLC | 588,442 | $12.5M | 3.19% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 826,936 | $17.5M | 0.04% | +476,874+136.2% | Added |
| Bain Capital Life Sciences Investors, LLC | 1,990,914 | $42.2M | 5.27% | +1,990,914 | New |
| OrbiMed Advisors LLC | 2,269,637 | $48.1M | 0.95% | +108,696+5.0% | Added |
| Novo Holdings A/S | 2,340,772 | $49.6M | 3.54% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 3,461,784 | $73.4M | 9.93% | 00.0% | Unchanged |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13−100.0% | Sold out |